The goal of this work was to modify the structural parameters of porphyrin-based agents to optimize their imaging and/or therapeutic potential. In order to achieve our goal, certain chlorins and bacteriochlorins were synthesized, their comparative photophysical properties as well as the impact of certain delivery vehicles in tumor-specificity were investigated. Finally, efforts were also made to develop target-specific multifunctional nanoplatforms by introducing tumor-targeting moieties at the surface of the nanoparticles.
The promising results of the parent compound 3-[1’-m-iodobenzyloxyethyl]-2-devinyl pyropheophorbide-a as a theranostic agent inspired us to develop of an improved agent with extended ring system. Among the compounds investigated, a reduced porphyrin (chlorin) bearing a cyclohexenone ring system produced excellent PET-imaging capability with reduced fluorescence imaging and PDT capabilities, due to limited singlet oxygen producing ability. Interestingly, compared to methyl 3(1’-benzyloxy)ethylpyropheophorbide-a the corresponding bacteriochlorin containing two reduced pyrrole rings diagonal to each other, retained its PDT and PET imaging abilities.
For investigating the utility of NIR bacteriopurpurinimides as theranostic agents, two structural isomers were derived from bacteriochlorophyll-a in which the five member isocyclic ring was extended to a six-member N-substituted imide ring system yielding the desired compounds (one isomer was found to be more effective than other) with good PDT, fluorescence and PET capabilities, but it also produced higher uptake in liver. On postloading the effective isomer in amino functionalized polyacrylamide nanoparticles reduced the liver uptake to some extent.
Finally, the nanoparticle project was further extended by developing polyacrylamide nanoparticles bearing folic acid moieties at the periphery, and a series of functionalized nanoparticles was synthesized and characterized for use in future studies. The initial results are quite promising and provide an opportunity to develop improved agents for cancer imaging with and without PDT. This approach is not limited to PDT and can be used for effective delivery of a variety of compounds, including chemotherapeutics with reduced toxicity.
|Advisor:||Pandey, Ravindra K.|
|Commitee:||Baier, Robert E., Kozbor-Fogelberg, Danuta, Mal, Asoke K., Nikiforov, Mikhail A.|
|School:||State University of New York at Buffalo|
|School Location:||United States -- New York|
|Source:||DAI-B 78/02(E), Dissertation Abstracts International|
|Subjects:||Biochemistry, Biophysics, Oncology|
|Keywords:||Bacteriochlorin, Cancer, Folic acid targeting targeted, Nanoparticle, Photodynamic therapy, Photosensitizer|
Copyright in each Dissertation and Thesis is retained by the author. All Rights Reserved
The supplemental file or files you are about to download were provided to ProQuest by the author as part of a
dissertation or thesis. The supplemental files are provided "AS IS" without warranty. ProQuest is not responsible for the
content, format or impact on the supplemental file(s) on our system. in some cases, the file type may be unknown or
may be a .exe file. We recommend caution as you open such files.
Copyright of the original materials contained in the supplemental file is retained by the author and your access to the
supplemental files is subject to the ProQuest Terms and Conditions of use.
Depending on the size of the file(s) you are downloading, the system may take some time to download them. Please be